Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Antibody therapies in CNS diseases.
Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan Province.
Osmotic demyelination syndrome complicating diabetes with anti-glutamic acid decarboxylase antibodies and Graves' disease: A case report.
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy.
Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator.
Cellulose/soy protein composite-based nerve guidance conduits with designed microstructure for peripheral nerve regeneration.
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction.
Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.
What do we know about brain contrast enhancement patterns in neuromyelitis optica?
A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights.
Bypassing hazard of housekeeping genes: their evaluation in rat granule neurons treated with cerebrospinal fluid of multiple sclerosis subjects.
Neurosarcoidosis: Clinical Features, Diagnosis, and Management.
Correction of Footdrop Due to Multiple Sclerosis Using the STIMuSTEP Implanted Dropped Foot Stimulator.
Deep morphea induced by interferon-β1b injection.
A Novel Asp121Asn Mutation of Myelin Protein Zero Is Associated with Late-Onset Axonal Charcot-Marie-Tooth Disease, Hearing Loss and Pupil Abnormalities.
X-ray radiation and the risk of multiple sclerosis: Do the site and dose of exposure matter?
Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1α for Th17 suppression.
Lung inflammation stalls Th17 cell migration en route to the central nervous system during the development of experimental autoimmune encephalomyelitis.
[Pathology, diagnosis, and treatment of combined central and peripheral demyelination].
Heat shock protein 70-hom gene polymorphism and protein expression in multiple sclerosis.
Good cardiac safety in patients with relapsing remitting multiple sclerosis upon first fingolimod dose.
Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis.
The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
Immunomodulation by vitamin D in multiple sclerosis: More than IL-17.
In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines.

Pages